0000950170-24-072420.txt : 20240612 0000950170-24-072420.hdr.sgml : 20240612 20240612160508 ACCESSION NUMBER: 0000950170-24-072420 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240610 FILED AS OF DATE: 20240612 DATE AS OF CHANGE: 20240612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Feller Faye CENTRAL INDEX KEY: 0001937361 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20859 FILM NUMBER: 241038397 MAIL ADDRESS: STREET 1: 919 EAST HILLSDALE BOULEVARD STREET 2: SUITE 250 CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GERON CORP CENTRAL INDEX KEY: 0000886744 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 752287752 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 919 EAST HILLSDALE BOULEVARD STREET 2: SUITE 250 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6504737700 MAIL ADDRESS: STREET 1: 919 EAST HILLSDALE BOULEVARD STREET 2: SUITE 250 CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: GERON CORPORATION DATE OF NAME CHANGE: 19960521 4 1 ownership.xml 4 X0508 4 2024-06-10 0000886744 GERON CORP GERN 0001937361 Feller Faye C/O GERON CORPORATION 919 E HILLSDALE BLVD. SUITE 250 FOSTER CITY CA 94404 false true false false EVP, Chief Medical Officer false Common Stock 2024-06-10 4 M false 112500 1.060 A 112500 D Common Stock 2024-06-10 4 M false 20000 1.060 A 20000 D Common Stock 2024-06-10 4 M false 155400 1.295 A 155400 D Common Stock 2024-06-10 4 S false 287900 4.634 D 0 D Stock Option (right to buy) 1.060 2024-06-10 4 M false 112500 0 D 2032-02-15 Common Stock 112500 87500 D Stock Option (right to buy) 1.060 2024-06-10 4 M false 20000 0 D 2032-02-15 Common Stock 20000 0 D Stock Option (right to buy) 1.295 2024-06-10 4 M false 155400 0 D 2030-02-11 Common Stock 155400 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.52 to $4.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. This option vests in a series of 48 consecutive equal monthly installments commencing February 16, 2022 (of which 112,500 shares were vested as of the exercise date), provided the optionee continues to provide services to the Company. Option fully vested. /s/ Scott A. Samuels for Faye Feller 2024-06-12